The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Fresenius Medical Care AG's Revenue for the
three
months ended in Mar. 2026 was $5,332 Mil. Fresenius Medical Care AG's average Accounts Receivable for the
three
months ended in Mar. 2026 was $3,921 Mil.
Hence, Fresenius Medical Care AG's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.36.
Fresenius Medical Care AG (NYSE:FMS) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Fresenius Medical Care AG Receivables Turnover Related Terms
Fresenius Medical Care AG Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius Medical Care AG Receivables Turnover Chart
FMS vs HCA, THC, DVA: Receivables Turnover Comparison
For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius Medical Care AG Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Fresenius Medical Care AG's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius Medical Care AG (FMS) has a Receivables Turnover of 1.36 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Fresenius Medical Care AG and its competitors. According to the industry distribution chart, Fresenius Medical Care AG ranks #431 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 65.6%.
Is Fresenius Medical Care AG's Receivables Turnover too high?
Fresenius Medical Care AG's current Receivables Turnover is 1.36. The Healthcare Providers & Services industry median Receivables Turnover is 7.68. Fresenius Medical Care AG's value of 1.36 is 82.3% below this industry median. Based on the distribution chart, Fresenius Medical Care AG ranks #431 out of 657 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Fresenius Medical Care AG has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's Receivables Turnover compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius Medical Care AG ranks #431 out of 657 companies for Receivables Turnover. This places Fresenius Medical Care AG in the lower half of its industry. The industry median Receivables Turnover is 7.68. Fresenius Medical Care AG's value of 1.36 is 82.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.68, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius Medical Care AG's current Receivables Turnover of 1.36 is 82.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Fresenius Medical Care AG and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius Medical Care AG's current Receivables Turnover is 1.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (FMS) is currently considered Fairly Valued. The stock's GF Value™ is $23.57, compared to a current price of $22.86 — trading 3% below its estimated fair value. The current Receivables Turnover is 1.36 and 82.3% below the Healthcare Providers & Services industry median of 7.68. Fresenius Medical Care AG's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Fresenius Medical Care AG (FMS), the current Receivables Turnover is 1.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius Medical Care AG (FMS) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued.
The current stock price of $22.86 is trading 3% below its estimated GF Value™ of $23.57.
GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.
Key valuation signals for FMS:
Receivables Turnover: 1.36
GF Value™: $23.57 vs. price of $22.86 (3% below fair value)
Industry Position: 82.3% below the Healthcare Providers & Services median (#431 of 657)
No single metric tells the full story. See the FMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
72GF Score
Get the complete analysis for FMS
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FMS has been successfully added to your 
